Normative reference ranges for echocardiographic chamber dimensions in a healthy Central European population: results from the Czech post-MONICA survey.


Journal

Cardiovascular ultrasound
ISSN: 1476-7120
Titre abrégé: Cardiovasc Ultrasound
Pays: England
ID NLM: 101159952

Informations de publication

Date de publication:
30 Oct 2019
Historique:
received: 08 07 2019
accepted: 04 10 2019
entrez: 1 11 2019
pubmed: 2 11 2019
medline: 13 5 2020
Statut: epublish

Résumé

Normative reference values for echocardiographic chamber quantification are of great importance; however, this can be challenging. Our aim was to derive these values including degrees of abnormality from a random Central European population sample with a homogeneous subset of healthy subjects. We analysed echocardiograms obtained in a randomly selected population sample during the Czech post-MONICA survey in 2007/2008. Overall, 1850 out of 2273 persons of the whole sample of three districts had adequate echocardiograms (81.4%). A healthy subgroup defined by the absence of known cardiovascular disease was used to define normal reference range limits (n = 575, median age 42 years [IQR 34-52], 57% females). The whole population sample with predefined percentile cut-offs was used to define degrees of abnormality. Left ventricular (LV) size tended to decrease with age, while LV mass increased with age in both males and females and in both the healthy and general populations. LV dimensions were larger in males, except for body surface area-indexed LV diameter. M-mode derived LV measurements were larger and LV mass higher compared to 2D measurements. Right ventricle basal dimension was larger in males. Our study provides reference ranges for echocardiographic measurements obtained in a healthy subgroup derived from an epidemiological study of a Central European population. Where feasible, degrees of abnormality are provided based on the whole population sample including patients with disease. Our data show that age, gender and measurement method significantly affect cardiac dimensions and function and should be always taken into account.

Sections du résumé

BACKGROUND BACKGROUND
Normative reference values for echocardiographic chamber quantification are of great importance; however, this can be challenging. Our aim was to derive these values including degrees of abnormality from a random Central European population sample with a homogeneous subset of healthy subjects.
METHODS METHODS
We analysed echocardiograms obtained in a randomly selected population sample during the Czech post-MONICA survey in 2007/2008. Overall, 1850 out of 2273 persons of the whole sample of three districts had adequate echocardiograms (81.4%). A healthy subgroup defined by the absence of known cardiovascular disease was used to define normal reference range limits (n = 575, median age 42 years [IQR 34-52], 57% females). The whole population sample with predefined percentile cut-offs was used to define degrees of abnormality.
RESULTS RESULTS
Left ventricular (LV) size tended to decrease with age, while LV mass increased with age in both males and females and in both the healthy and general populations. LV dimensions were larger in males, except for body surface area-indexed LV diameter. M-mode derived LV measurements were larger and LV mass higher compared to 2D measurements. Right ventricle basal dimension was larger in males.
CONCLUSIONS CONCLUSIONS
Our study provides reference ranges for echocardiographic measurements obtained in a healthy subgroup derived from an epidemiological study of a Central European population. Where feasible, degrees of abnormality are provided based on the whole population sample including patients with disease. Our data show that age, gender and measurement method significantly affect cardiac dimensions and function and should be always taken into account.

Identifiants

pubmed: 31666068
doi: 10.1186/s12947-019-0172-0
pii: 10.1186/s12947-019-0172-0
pmc: PMC6822480
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

22

Subventions

Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : 15-27109A
Organisme : Univerzita Karlova v Praze
ID : PROGRES Q38/LF1

Références

Am J Cardiol. 1989 Nov 1;64(16):1066-8
pubmed: 2530879
Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):680-90
pubmed: 24451180
Circulation. 2012 Dec 4;126(23):2713-9
pubmed: 23124035
J Hum Hypertens. 2012 Jul;26(7):420-9
pubmed: 21633379
J Am Soc Echocardiogr. 1995 Nov-Dec;8(6):793-800
pubmed: 8611279
Atherosclerosis. 2010 Aug;211(2):676-81
pubmed: 20471016
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Circ J. 2008 Nov;72(11):1859-66
pubmed: 18827372
Circ Cardiovasc Imaging. 2013 Nov;6(6):1073-9
pubmed: 24014823
J Hypertens. 2010 Nov;28(11):2196-203
pubmed: 20651603
Circulation. 1995 Aug 15;92(4):835-41
pubmed: 7641364
Circ Cardiovasc Imaging. 2010 Sep;3(5):614-22
pubmed: 20581050
JACC Cardiovasc Imaging. 2015 Jun;8(6):656-65
pubmed: 25981507
Circulation. 1997 Sep 16;96(6):1863-73
pubmed: 9323074
J Am Soc Echocardiogr. 2001 Jun;14(6):601-11
pubmed: 11391289
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Am J Cardiol. 1986 Feb 15;57(6):450-8
pubmed: 2936235

Auteurs

Josef Marek (J)

2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Praha 2, Czech Republic.

Jean-Claude Lubanda (JC)

2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Praha 2, Czech Republic.

Renata Cifkova (R)

2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Praha 2, Czech Republic.
Center for Cardiovascular Prevention, First Faculty of Medicine, Charles University in Prague and Thomayer Hospital, Prague, Czech Republic.

Petr Kuchynka (P)

2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Praha 2, Czech Republic.

Lubor Golan (L)

2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Praha 2, Czech Republic.

Eduard Nemcek (E)

2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Praha 2, Czech Republic.

Ales Linhart (A)

2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Praha 2, Czech Republic. alinh@lf1.cuni.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH